“GLP-1” supplements and patches contain no GLP-1 drug. Most sell berberine, fiber, probiotics such as Akkermansia, or plant extracts. The most favorable berberine analysis found about 2 kg (4.6 lb) of weight loss beyond placebo, and fiber analyses found none, against 15.3 kg vs 2.6 kg with semaglutide in its main trial.[1][9]
The name does a lot of work. A GLP-1 receptor agonist such as semaglutide or tirzepatide is a prescription drug that binds the GLP-1 receptor directly, at levels far above what your gut makes after a meal. A “GLP-1 supplement” is a dietary supplement whose maker hopes it will nudge your own GLP-1 up a little. Those are different products with different evidence, and this page grades each common ingredient against its trials. It is not a case against supplements. Some of these ingredients have real, modest effects. None of them belongs in the same sentence as the drugs.
What is actually in a “GLP-1 supplement”?
Read the supplement-facts panel and you will usually find one or more of these: berberine or dihydroberberine, a soluble fiber (psyllium, glucomannan, inulin), a probiotic or “postbiotic” (Akkermansia, Clostridium butyricum, bifidobacteria), or plant extracts. What you will not find is a GLP-1 receptor agonist. Those are prescription drugs, and a product that contained one would not be a legal supplement.
Because supplements do not need FDA approval before sale, the label claim is the maker’s. FDA does act on new ingredients it considers unsafe. In August 2026 it sent a warning letter to the maker of a supplement sold as a “GLP-1 Biomimetic,” finding that its yeast-derived peptide ingredient was a new dietary ingredient without adequate safety information, which made the product adulterated.[10] A product name with “GLP-1” in it tells you what the maker wants you to think of, not what the product does.
| Ingredient | Raises GLP-1 in people? | Weight result in trials | Our grade |
|---|---|---|---|
| Berberine | Shown in lab cells, not measured in the weight trials | −2.07 kg in one meta-analysis; no significant change in another | Weak and mixed |
| Pasteurized Akkermansia | Higher GLP-1 after a glucose drink in one exploratory analysis | −2.27 kg vs placebo (P = 0.091) in a 32-person pilot; 2 kg less regain in a 90-person trial | Early, maker-funded |
| Multi-strain probiotic with inulin | Not reported in the trial abstract | Glucose and A1c improved; weight not a reported outcome | Glucose signal only |
| Psyllium | Not the outcome tested | −0.28 kg, not significant (22 RCTs) | No weight effect |
| Glucomannan | Not the outcome tested | −0.22 kg, not significant (8 RCTs) | No weight effect |
| 'GLP-1 patch' | No data | No published controlled trial found | Untested |
Does berberine work like a GLP-1 drug?
Berberine is the ingredient behind the “nature’s Ozempic” nickname, and the GLP-1 link is real at the cell level. In a 2015 study, berberine triggered GLP-1 release from human enteroendocrine cells grown in a dish, through a bitter-taste receptor.[3] That is a mechanism, not an outcome, and the human weight trials did not measure GLP-1 at all.
On weight, the evidence splits. Asbaghi and colleagues pooled 12 randomized trials and found berberine lowered body weight by 2.07 kg (95% CI −3.09 to −1.05, P < 0.001) and waist circumference by about 1 cm.[1] Amini and colleagues pooled 12 trials of berberine and barberry (849 people) the same year and found no significant change in body weight (−0.11 kg, P = 0.83) or BMI, only a small drop in waist-to-hip ratio.[2] Take the generous reading and berberine is worth a few pounds. Take the cautious one and it is worth nothing measurable on the scale. Our berberine vs Ozempic comparison goes through the mechanism and magnitude gaps, and the berberine evidence review covers its blood-sugar data, which are stronger than its weight data. Dihydroberberine, a form sold for better absorption, has even less outcome evidence; see dihydroberberine.
Do Akkermansia and fiber products raise GLP-1?
Pasteurized Akkermansia muciniphila is the one supplement ingredient where a human trial actually measured GLP-1. In a 2026 trial of 142 adults with metabolic syndrome, four months of 30 billion pasteurized cells a day did not improve the main outcome, whole-body insulin sensitivity. In follow-up analyses, the treated group had a larger GLP-1 rise after a glucose drink than placebo (P < 0.01), and people who started with little Akkermansia in their gut did better.[5] Those are exploratory findings from a trial that missed its primary endpoint.
The weight data are small. In the 2019 pilot, 32 people completed three months and the pasteurized group lost 2.27 kg more than placebo, a difference that did not reach significance (P = 0.091).[4] In a 2026 trial of 90 adults who first lost weight on a low-calorie diet, those on pasteurized Akkermansia regained 1.2 kg over 24 weeks versus 3.2 kg on placebo (P = 0.012).[6] That is a real result about keeping weight off, from a trial whose authors include the ingredient maker’s staff. Both 2026 trials list employees or consultants of the ingredient’s maker among their authors. Our Akkermansia evidence review covers each trial in detail.
One multi-strain probiotic sold for blood sugar has a trial too. In 76 adults with type 2 diabetes, a five-strain formula with inulin and Akkermansia lowered the after-meal glucose curve by 36.1 mg/dL over 180 minutes (P = 0.05) and A1c by 0.6 points against placebo over 12 weeks. All the authors worked for the company, the sample was small, and the abstract reports no GLP-1 or weight result.[7]
Fiber has the most trials and the plainest answer. A meta-analysis of 22 randomized trials of psyllium found no significant effect on body weight (−0.28 kg, 95% CI −0.78 to 0.21).[8] One of glucomannan found the same: −0.22 kg across eight trials, not significant, with abdominal discomfort, diarrhea and constipation as side effects.[11] Fiber can help with fullness and regularity. It does not act like a weight-loss drug. Butyrate, the gut-bacteria product some of these formulas aim to raise, is covered in our butyrate review.
Do GLP-1 patches work?
We found no published controlled trial of a “GLP-1 patch” for weight loss in PubMed, searching on October 2, 2026. A patch sold as a supplement cannot contain a GLP-1 drug, so whatever it delivers is a supplement ingredient. Whether useful amounts of any such ingredient cross the skin has not been shown, and the capsule versions of the usual ingredients have the modest or null results above. The transdermal research that does exist is on delivery devices for real peptide drugs, which is a different thing from a supplement sticker.
How much weight do supplement trials show, compared with prescription GLP-1s?
Put the numbers on one scale and the gap is the story. The figures below are each source’s own headline result. The trials differ in length and population, so read them as orders of magnitude, not a head-to-head ranking.
| Product | Trial evidence | Weight result |
|---|---|---|
| Glucomannan | Meta-analysis, 8 RCTs | −0.22 kg vs placebo, not significant |
| Psyllium | Meta-analysis, 22 RCTs | −0.28 kg vs placebo, not significant |
| Berberine | Meta-analyses, 12 RCTs each | −0.11 kg (not significant) to −2.07 kg vs placebo |
| Pasteurized Akkermansia | Pilot RCT, 32 completers, 3 months | −2.27 kg vs placebo, P = 0.091 |
| Semaglutide 2.4 mg | STEP 1, 1,961 adults, 68 weeks | −14.9% vs −2.4% (−15.3 kg vs −2.6 kg) |
| Tirzepatide 15 mg | SURMOUNT-1, 2,539 adults, 72 weeks | −20.9% vs −3.1% with placebo |
Are GLP-1 supplements safe to take with Ozempic or Zepbound?
Tell your prescriber about every supplement you take, because some overlap with the drug. Berberine lowers blood sugar, and the Zepbound label warns that tirzepatide combined with insulin or an insulin secretagogue such as a sulfonylurea “may increase the risk of hypoglycemia, including severe hypoglycemia.”[12] Adding another glucose-lowering product makes that conversation more important, not less. Fiber supplements and the GLP-1 drugs both act on the gut, so bloating or constipation can add up; our GLP-1 side-effects guide covers what helps. There is no evidence that any supplement increases the drug’s effect.
If you want the real drug, what does it cost?
Prescription GLP-1s come branded (with or without insurance) or compounded, and price swings widely by route. Our GLP-1 cost and insurance guide explains each path. To compare telehealth services, see Ozempic alternatives or, if price comes first, the lowest published semaglutide prices.
The bottom line
A “GLP-1 supplement” is a marketing category, not a drug class. Berberine has a lab mechanism and a few pounds of weight loss in its best analysis. Pasteurized Akkermansia has early, company-funded data, including the only human GLP-1 measurement. Fiber has many trials and no weight effect, and patches have no trials at all. If the goal is the weight loss people associate with GLP-1 drugs, the only products that have delivered it in trials are the prescription drugs themselves.